Concepedia

Nicola Consalvo

NC

Statistics

Publications

3

Citations

91

H-Index

3

Active since

2016

Affiliations

Roche (Switzerland)(Current)

Nicola Consalvo is an author at Roche (Switzerland) specializing in oncology, pharmacology, and therapy response assessment.

Publications per year

2016–2019

3

Publications

3

Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial

Ulrich Hacker, Laura Escalona-Espinosa, Nicola Consalvo et al. · British Journal of Cancer · 2016 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial

Mogens K. Boisen, Camilla Bjørnbak Holst, Nicola Consalvo et al. · Oncotarget · 2017 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

From waterfall plots to spaghetti plots in early oncology clinical development

François Mercier, Nicola Consalvo, Nicolas Frey et al. · Pharmaceutical Statistics · 2019 · 15 citations

Computing, Biostatistics, Oncology +16

1–3 of 3